For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Qualigen Therapeutics Inc (NASDAQ: QLGN) closed the day trading at $2.86 up 4.00% from the previous closing price of $2.75. In other words, the price has increased by $4.00 from its previous closing price. On the day, 0.56 million shares were traded. QLGN stock price reached its highest trading level at $3.0034 during the session, while it also had its lowest trading level at $2.6601.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QLGN now has a Market Capitalization of 5814585 and an Enterprise Value of 10924129.
Stock Price History:
The Beta on a monthly basis for QLGN is 0.21, which has changed by -0.4222222 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, QLGN has reached a high of $8.81, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -13.24%, while the 200-Day Moving Average is calculated to be -13.61%.
Shares Statistics:
Over the past 3-months, QLGN traded about 2.54M shares per day on average, while over the past 10 days, QLGN traded about 6629320 shares per day. A total of 2.66M shares are outstanding, with a floating share count of 2.44M. Insiders hold about 8.20% of the company’s shares, while institutions hold 0.47% stake in the company. Shares short for QLGN as of 1760486400 were 155210 with a Short Ratio of 0.06, compared to 1757894400 on 39494. Therefore, it implies a Short% of Shares Outstanding of 155210 and a Short% of Float of 7.630000000000001.
